H1N1 Vaccines

Global Market Trajectory & Analytics

MCP-6274

EXECUTIVE ENGAGEMENTS

POOL

6346
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

1013
Interactions with Platform & by Email

PARTICIPANTS

192
Unique # Participated

VALIDATIONS

41
Responses Validated*

COMPANIES

33
Responses Validated*
* Login for a full stack data experience

DATE

JAN 2022

TABLES

201

PAGES

268

EDITION

15

PRICE

USD 5450

CODE

MCP-6274


COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)

S M N T

%

VALIDATED RESEARCH *

S M N T
S M N T
S M N T
S M N T
S M N T
S M N T
S M N T
S M N T
S M N T
S M N T

* S = Strong; M = Moderate; N = Niche; T= Trivial (<1%)
* Login to Participate & View Data Stacks
* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlassTM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.
View All Companies...

PARTICIPATE NOW!
  

HIGHLIGHTS & REPORT INDEX

Amid the COVID-19 crisis, the global market for H1N1 Vaccines estimated at US$4.4 Billion in the year 2020, is projected to reach a revised size of US$5.7 Billion by 2027, growing at a CAGR of 3.6% over the period 2020-2027.
The H1N1 Vaccines market in the U.S. is estimated at US$1.2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2027 trailing a CAGR of 6.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.1% and 2.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 1.8% CAGR.

SELECT PLAYERS

Abbott Laboratories, Inc.; Baxter International, Inc.; Cipla Ltd.; GlaxoSmithKline PLC; Hualan Biological Engineering, Inc.; Merck & Co., Inc.; Mitsubishi Tanabe Pharma Corporation; Pfizer, Inc.; Sanofi; Sinovac Biotech Ltd.

SEGMENTS

» H1N1 Vaccines

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for H1N1 Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for H1N1 Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2020 & 2027
UNITED STATES
USA Current & Future Analysis for H1N1 Vaccines by Segment - H1N1 Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
CANADA
Canada Current & Future Analysis for H1N1 Vaccines by Segment - H1N1 Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
JAPAN
Japan Current & Future Analysis for H1N1 Vaccines by Segment - H1N1 Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
CHINA
China Current & Future Analysis for H1N1 Vaccines by Segment - H1N1 Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
EUROPE
Europe Current & Future Analysis for H1N1 Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for H1N1 Vaccines by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2020 & 2027
FRANCE
France Current & Future Analysis for H1N1 Vaccines by Segment - H1N1 Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
GERMANY
Germany Current & Future Analysis for H1N1 Vaccines by Segment - H1N1 Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
ITALY
Italy Current & Future Analysis for H1N1 Vaccines by Segment - H1N1 Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UNITED KINGDOM
UK Current & Future Analysis for H1N1 Vaccines by Segment - H1N1 Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
SPAIN
Spain Current & Future Analysis for H1N1 Vaccines by Segment - H1N1 Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
RUSSIA
Russia Current & Future Analysis for H1N1 Vaccines by Segment - H1N1 Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
REST OF EUROPE
Rest of Europe Current & Future Analysis for H1N1 Vaccines by Segment - H1N1 Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for H1N1 Vaccines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for H1N1 Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2020 & 2027
AUSTRALIA
Australia Current & Future Analysis for H1N1 Vaccines by Segment - H1N1 Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
INDIA
India Current & Future Analysis for H1N1 Vaccines by Segment - H1N1 Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
SOUTH KOREA
South Korea Current & Future Analysis for H1N1 Vaccines by Segment - H1N1 Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
REST OF ASIA-PACIFIC
Rest of Asia-Pacific Current & Future Analysis for H1N1 Vaccines by Segment - H1N1 Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
LATIN AMERICA
Latin America Current & Future Analysis for H1N1 Vaccines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Latin America 7-Year Perspective for H1N1 Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2020 & 2027
ARGENTINA
Argentina Current & Future Analysis for H1N1 Vaccines by Segment - H1N1 Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
BRAZIL
Brazil Current & Future Analysis for H1N1 Vaccines by Segment - H1N1 Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
MEXICO
Mexico Current & Future Analysis for H1N1 Vaccines by Segment - H1N1 Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
REST OF LATIN AMERICA
Rest of Latin America Current & Future Analysis for H1N1 Vaccines by Segment - H1N1 Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
MIDDLE EAST
Middle East Current & Future Analysis for H1N1 Vaccines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Middle East 7-Year Perspective for H1N1 Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2020 & 2027
IRAN
Iran Current & Future Analysis for H1N1 Vaccines by Segment - H1N1 Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
ISRAEL
Israel Current & Future Analysis for H1N1 Vaccines by Segment - H1N1 Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
SAUDI ARABIA
Saudi Arabia Current & Future Analysis for H1N1 Vaccines by Segment - H1N1 Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UNITED ARAB EMIRATES
UAE Current & Future Analysis for H1N1 Vaccines by Segment - H1N1 Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
REST OF MIDDLE EAST
Rest of Middle East Current & Future Analysis for H1N1 Vaccines by Segment - H1N1 Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
AFRICA
Africa Current & Future Analysis for H1N1 Vaccines by Segment - H1N1 Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Total Companies Profiled: 33

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com